Form 4 for INCY Incyte
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-06 · accession 0000879169-24-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-08 | 2024-11-06 | INCY | Flannelly Barry P | EVP, General Manager US | S - Sale+OE | $79.68 | -3,680 | 60.3K | -6% | -$293.2K |
| DM | 2024-11-08 | 2024-11-06 | INCY | Flannelly Barry P | EVP, General Manager US | M - OptEx | $70.03 | +3,680 | 59.5K | +7% | +$257.7K |
| DM | 2024-11-08 | 2024-11-06 | INCY | Flannelly Barry P | EVP, General Manager US | M - OptEx | $0.00 | -3,680 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | S | D | 2,256 | $78.21 | 58,042 | D | — | — | (F1) This includes an aggregate of 46,105 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. |
| 2 | Common | Common Stock | 2024-11-06 | S | D | 1,424 | $82.00 | 60,298 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-06 | M | A | 2,256 | $68.62 | 61,722 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-06 | M | A | 1,424 | $72.27 | 59,466 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2024-11-06 | M | D | 1,424 | $0.00 | 0 | D | $72.27 · — to 2029-01-03 | 1,424 Common Stock | (F2) Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2024-11-06 | M | D | 2,256 | $0.00 | 0 | D | $68.62 · — to 2028-07-01 | 2,256 Common Stock | (F3) Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. |